Zygosids - A Novel Family of Drug Candidates for Treatment of T2D Acting via Robust Reduction of Insulin Resistance
Metabolism: Clinical and Experimental - Netherlands
doi 10.1016/j.metabol.2019.12.043
Full Text
Open PDFAbstract
Available in full text
Date
March 1, 2020
Authors
Publisher
Elsevier BV